[PDF] ERGOMED

What does ergomed do?

Operating with a global footprint in around 100 countries, Ergomed provides its clients with access to solutions for the most demanding clinical projects. Global, full-service Phase I-IV clinical development and trial management services. Innovative services for emerging companies to meet their regulatory obligations.

How much does ergomed pay per share?

The cash offer for 1,350 pence per share represents a premium of about 28% to Ergomed's last closing price and has the backing of the board, the joint statement said. Surrey-based Ergomed provides clinical research and trial management services, employs more than 1,800 people and operates out of 24 offices in around 100 countries.

How many followers does ergomed have?

ERGOMED | 29,701 followers on LinkedIn. Global Provider of Expert, High-Quality Services to the Biopharmaceutical Industry.

Why did ergomed acquire O+P & GASD?

German-based CRO company, O+P, and GASD, a biostatistics company, is acquired to bolster Ergomed’s full-service offering. Ergomed acquires leading pharmacovigilance and regulatory services business, PharmInvent. Ergomed acquires PSR Group BV, a specialist orphan drug CRO, to further enhance its expertise in rare diseases.